scPharmaceuticals Inc. (NASDAQ: SCPH) stock fell -1.82% on Friday to $7.02 against a previous-day closing price of $7.15. With 0.55 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.39 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $7.15 whereas the lowest price it dropped to was $6.90. The 52-week range on SCPH shows that it touched its highest point at $12.75 and its lowest point at $3.68 during that stretch. It currently has a 1-year price target of $19.33. Beta for the stock currently stands at 0.18.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SCPH was down-trending over the past week, with a drop of -5.26%, but this was down by -10.00% over a month. Three-month performance dropped to -34.76% while six-month performance fell -2.90%. The stock gained 48.73% in the past year, while it has lost -2.09% so far this year. A look at the trailing 12-month EPS for SCPH yields -1.33 with Next year EPS estimates of -1.14. For the next quarter, that number is -0.36. This implies an EPS growth rate of -13.80% for this year and 18.60% for next year.
Float and Shares Shorts:
At present, 38.69 million SCPH shares are outstanding with a float of 31.96 million shares on hand for trading. On Aug 30, 2023, short shares totaled 6.71 million, which was 18.70% higher than short shares on Jul 30, 2023. In addition to Mr. John H. Tucker as the firm’s Pres, CEO, Principal Exec. Officer & Director, Ms. Rachael Nokes serves as its CFO & Principal Accounting Officer.
Institutional Ownership:
Through their ownership of 75.58% of SCPH’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 48.28% of SCPH, in contrast to 40.77% held by mutual funds. Shares owned by individuals account for 12.94%. As the largest shareholder in SCPH with 9.20% of the stake, RTW Investments LP holds 3,297,843 shares worth 3,297,843. A second-largest stockholder of SCPH, AIGH Capital Management LLC, holds 2,051,805 shares, controlling over 5.72% of the firm’s shares. Cowen & Co. LLC is the third largest shareholder in SCPH, holding 1,837,918 shares or 5.13% stake. With a 2.09% stake in SCPH, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 749,134 shares are owned by the mutual fund manager. The iShares Russell 2000 ETF, which owns about 1.77% of SCPH stock, is the second-largest Mutual Fund holder. It holds 634,054 shares valued at 4.87 million. SPDR S&P Kensho New Economies Com holds 1.52% of the stake in SCPH, owning 544,237 shares worth 4.18 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, SCPH reported revenue of $0.00 and operating income of -$9.42M. The EBITDA in the recently reported quarter was -$9.12M and diluted EPS was -$0.35.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SCPH since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With SCPH analysts setting a high price target of $25.00 and a low target of $16.00, the average target price over the next 12 months is $19.33. Based on these targets, SCPH could surge 256.13% to reach the target high and rise by 127.92% to reach the target low. Reaching the average price target will result in a growth of 175.36% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded SCPH stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 4 while that of sell transactions has risen to 7 over the past year. The total number of shares bought during that period was 882,995 while 610,288 shares were sold.
